NO20055205L - 4-(2-fcnylsulfanyl-fenyl)-1,2,3,6-tydropyridinderivater som serotoniniopptaksinhibitorer - Google Patents

4-(2-fcnylsulfanyl-fenyl)-1,2,3,6-tydropyridinderivater som serotoniniopptaksinhibitorer

Info

Publication number
NO20055205L
NO20055205L NO20055205A NO20055205A NO20055205L NO 20055205 L NO20055205 L NO 20055205L NO 20055205 A NO20055205 A NO 20055205A NO 20055205 A NO20055205 A NO 20055205A NO 20055205 L NO20055205 L NO 20055205L
Authority
NO
Norway
Prior art keywords
tithropyridine
phenylsulfanyl
phenyl
derivatives
uptake inhibitors
Prior art date
Application number
NO20055205A
Other languages
English (en)
Inventor
Jan Kehler
Benny Bang-Andersen
Thomas Ruhland
Kim Andersen
Ask Pueschl
Karsten Juhl
Morten Jorgensen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35432910&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20055205(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20055205L publication Critical patent/NO20055205L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

Oppfinnelsen tilveiebringer forbindelser representert ved den generelle formel I hvori substituentene er definert i søknaden. Forbindelsene er nyttige i behandlingen av en affektiv lidelse, inklusive depresjon, angstlidelser inklusive generell angstlidelse og panikklidelse og obsessiv-kompulsiv lidelse.
NO20055205A 2003-04-04 2005-11-04 4-(2-fcnylsulfanyl-fenyl)-1,2,3,6-tydropyridinderivater som serotoniniopptaksinhibitorer NO20055205L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200300518 2003-04-04
PCT/DK2004/000243 WO2004087662A1 (en) 2003-04-04 2004-04-02 4-(2-phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors

Publications (1)

Publication Number Publication Date
NO20055205L true NO20055205L (no) 2005-11-04

Family

ID=35432910

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055205A NO20055205L (no) 2003-04-04 2005-11-04 4-(2-fcnylsulfanyl-fenyl)-1,2,3,6-tydropyridinderivater som serotoniniopptaksinhibitorer

Country Status (28)

Country Link
US (1) US20070173522A1 (no)
EP (1) EP1613594B1 (no)
JP (1) JP2006522029A (no)
KR (1) KR20060021825A (no)
CN (1) CN100384822C (no)
AR (1) AR043964A1 (no)
AT (1) ATE390413T1 (no)
AU (1) AU2004226319A1 (no)
BR (1) BRPI0408453A (no)
CA (1) CA2521172A1 (no)
CL (1) CL2004000730A1 (no)
CO (1) CO5700777A2 (no)
DE (1) DE602004012724T2 (no)
DK (1) DK1613594T3 (no)
EA (1) EA009282B1 (no)
ES (1) ES2301979T3 (no)
HK (1) HK1090051A1 (no)
HR (1) HRP20080243T3 (no)
IS (1) IS8007A (no)
MX (1) MXPA05010678A (no)
NO (1) NO20055205L (no)
NZ (1) NZ541944A (no)
PL (1) PL1613594T3 (no)
PT (1) PT1613594E (no)
SI (1) SI1613594T1 (no)
UA (1) UA81300C2 (no)
WO (1) WO2004087662A1 (no)
ZA (1) ZA200507182B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004226838B8 (en) 2003-04-04 2009-06-11 H. Lundbeck A/S 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors
JP5173190B2 (ja) 2004-08-25 2013-03-27 武田薬品工業株式会社 腹圧性尿失禁の予防・治療剤及びそのスクリーニング方法
EP2018863B9 (en) 2006-05-16 2015-02-18 Takeda Pharmaceutical Company Limited Fused heterocyclic compound and use thereof
US20100266504A1 (en) 2007-11-15 2010-10-21 Takahiro Matsumoto Condensed pyridine derivative and use thereof
UA98698C2 (en) * 2008-03-03 2012-06-11 Х. Луннбек А/С Phenylsulfanylphenyl-piperidines and process for the preparation thereof
EP2510949A4 (en) 2009-12-11 2013-11-13 Astellas Pharma Inc THERAPEUTICS FOR FIBROMYALGIA
EP2930171A1 (en) * 2014-04-07 2015-10-14 LEK Pharmaceuticals d.d. Synthesis of vortioxetine via (2,4-dimethylphenyl)(2-iodophenyl)sulfane intermediate
CN105294554B (zh) * 2015-11-18 2017-11-07 乳源瑶族自治县大众药品贸易有限公司 苯基哌嗪衍生物及其使用方法和用途
US20210052600A1 (en) 2017-12-27 2021-02-25 Takeda Pharmaceutical Company Limited Therapeutic agents for stress urinary incontinence and incotinence of feces

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803143A (en) * 1969-09-08 1974-04-09 Eisai Co Ltd 6-amino alkylene 6,7-dihydro-5h-dibenzo (b,g),(1,5)thiazocines
US4018830A (en) * 1969-09-22 1977-04-19 Merck & Co., Inc. Phenylthioaralkylamines
US4055665A (en) * 1974-11-25 1977-10-25 Merck & Co., Inc. Treating arrythmia with phenylthioaralkylamines
US4066654A (en) * 1975-04-16 1978-01-03 G. D. Searle & Co. 1-triarylalkyl-4-phenyl-4-piperidine carboxylic acids and derivatives
US4056632A (en) * 1975-07-21 1977-11-01 Burroughs Wellcome Co. 2-Hydroxymethyl-2'-aminomethyl-diphenylsulfides and method of use
US4241071A (en) * 1977-01-27 1980-12-23 American Hoechst Corporation Antidepressant (α-phenyl-2-tolyl)azacycloalkanes
DE2802306A1 (de) * 1977-01-27 1978-08-10 Hoechst Ag Azacycloalkane, azacycloalkene und ihre derivate
US4198419A (en) * 1979-01-10 1980-04-15 American Hoechst Corporation Phenylthiophenylpiperidines
US4198417A (en) * 1979-01-10 1980-04-15 American Hoechst Corporation Phenoxyphenylpiperidines
GB8912971D0 (en) * 1989-06-06 1989-07-26 Wellcome Found Halogen substituted diphenylsulfides
US6410736B1 (en) * 1999-11-29 2002-06-25 Pfizer Inc. Biaryl ether derivatives useful as monoamine reuptake inhibitors
AU769430B2 (en) * 1999-10-13 2004-01-29 Pfizer Products Inc. Biaryl ether derivatives useful as monoamine reuptake inhibitors
AU2152101A (en) * 1999-12-30 2001-07-16 H. Lundbeck A/S Substituted phenyl-piperazine derivatives, their preparation and use
US6436938B1 (en) * 2001-01-22 2002-08-20 Pfizer Inc. Combination treatment for depression
US20020107244A1 (en) * 2001-02-02 2002-08-08 Howard Harry R. Combination treatment for depression
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну

Also Published As

Publication number Publication date
CO5700777A2 (es) 2006-11-30
SI1613594T1 (sl) 2008-08-31
PL1613594T3 (pl) 2008-09-30
DE602004012724T2 (de) 2009-04-09
HK1090051A1 (en) 2006-12-15
AR043964A1 (es) 2005-08-17
NZ541944A (en) 2008-05-30
CL2004000730A1 (es) 2005-02-18
PT1613594E (pt) 2008-07-01
IS8007A (is) 2005-08-29
MXPA05010678A (es) 2005-12-12
CN100384822C (zh) 2008-04-30
ZA200507182B (en) 2006-12-27
WO2004087662A1 (en) 2004-10-14
AU2004226319A1 (en) 2004-10-14
US20070173522A1 (en) 2007-07-26
BRPI0408453A (pt) 2006-04-04
EP1613594A1 (en) 2006-01-11
DK1613594T3 (da) 2008-07-14
EP1613594B1 (en) 2008-03-26
EA009282B1 (ru) 2007-12-28
EA200501579A1 (ru) 2006-04-28
ATE390413T1 (de) 2008-04-15
HRP20080243T3 (en) 2009-04-30
CN1777585A (zh) 2006-05-24
CA2521172A1 (en) 2004-10-14
DE602004012724D1 (de) 2008-05-08
KR20060021825A (ko) 2006-03-08
UA81300C2 (en) 2007-12-25
ES2301979T3 (es) 2008-07-01
JP2006522029A (ja) 2006-09-28

Similar Documents

Publication Publication Date Title
HRP20080478T3 (en) 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors
NO20055205L (no) 4-(2-fcnylsulfanyl-fenyl)-1,2,3,6-tydropyridinderivater som serotoniniopptaksinhibitorer
RS20120158A3 (en) Phenyl-piperazine Derivatives As Serotonin Resorption Inhibitors
NO20060402L (no) 3-amino choman og 2-aminotetralinderivater
HRP20080262T3 (en) 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
NO20062256L (no) Hydroksyalkylsubstituerte pyrido-7-pyrimidin-7-oner
NO20055750L (no) Nye kjemiske forbindelser
ATE396970T1 (de) 2-(1h-indolylsulfanyl)-benzylaminderivate als ssri
DE602004006118D1 (de) 2,3,4,5-TETRAHYDROBENZOiFöi1,4öOXAZEPIN-5-CARBONSÄUREAMID DERIVATE ALS GAMMA-SECRETASE INHIBITOREN ZUR BEHANDLUNG VON ALZHEIMER
ATE471320T1 (de) 4-aminopiperidinderivate als inhibitoren der monoamin-aufnahme
UA81469C2 (en) 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
NO20053562L (no) Nye aminobenzofenonforbindelser
EA200501577A1 (ru) Производные 4-(2-фенилсульфанилфенил)пиперидина в качестве ингибиторов повторного поглощения серотонина
NO20062700L (no) Morfolinderivater som norepinefrin reopptaksinhibitorer
ATE423772T1 (de) Morpholinderivate als inhibitoren der wiederaufnahme von norepinephrin
CA2521030A1 (en) 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
TH83467B (th) เฮทเทอโรไซเคิลตัวใหม่

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104